Please login to the form below

Not currently logged in
Email:
Password:

Lonza

This page shows the latest Lonza news and features for those working in and with pharma, biotech and healthcare.

Moderna wins EU authorisation for COVID-19 vaccine

Moderna wins EU authorisation for COVID-19 vaccine

Moderna’s European manufacturing partner Lonza received authorisation from Swiss regulators last week to begin producing mRNA-1273 at its plant in Switzerland.

Latest news

More from news
Approximately 2 fully matching, plus 16 partially matching documents found.

Latest Intelligence

  • Cell and gene therapy Cell and gene therapy

    Lonza has worked with 150 cell and gene therapy developers and each project has required a different approach, Hong added. ... As a result, Lonza’s efforts to reduce cell and gene therapy production costs involve logistics, said Hong.

  • Deal Watch February 2017 Deal Watch February 2017

    Licence. 320. Lonza/ Sanofi. Large scale mammalian cell manufacturing facility for antibody therapeutics.

  • Deal Watch December 2016 Deal Watch December 2016

    Headline $m. Capsugel (US). Lonza (Switzerland). Acquisition. Oral delivery technologies, development, formulation and manufacturing for pharma, consumer and nutrition products. ... LifeCell. Allergan. 12.3%. Vascular Solutions. Teleflex. 8.8%. Capsugel.

  • Biosimilars in China Biosimilars in China

    Several joint venture deals between MNCs and Chinese players have been sealed recently: Hisun with Pfizer, Simcere with Merck and Fosun with Lonza.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 6 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....